Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly's Diabetes Setbacks May Spur Shopping Spree Beyond Amylin
Lilly's Diabetes Setbacks May Spur Shopping Spree Beyond Amylin
Lilly's Diabetes Setbacks May Spur Shopping Spree Beyond Amylin
Submitted by
admin
on October 23, 2010 - 12:39pm
Source:
Bloomberg
News Tags:
Eli Lilly
diabetes
Amylin
Pfizer
Sanofi
Cephalon
Headline:
Lilly's Diabetes Setbacks May Spur Shopping Spree Beyond Amylin
Do Not Allow Advertisers to Use My Personal information
